CD274 and colorectal carcinoma: Finally, as the mechanisms responsible for distinct responses to PD-1/PD-L1 mAbs in patients with CRC are elucidated, how to convert a ‘nonimmunogenic’ CRC into an ‘immunogenic’ CRC becomes a critical important issue (18, 117).